US Pharma Lobbying Trump Against Severe Anti-China Curbs — NYT

asiafinancial.com/us-pharma-lobbying-trump-against-severe-anti-china-curbs-nyt

A proposed executive order from Washington that could impose severe restrictions on medicines and experimental treatments from China has divided US President Donald’s Trump’s backers and American pharmaceutical companies, according a report by The New York Times.
The draft order proposes…

This story appeared on asiafinancial.com, 2025-09-15 15:28:14.
The Entire Business World on a Single Page. Free to Use →